Regeneron Shares Surge as Antibody Cocktail Cuts COVID-19 Risk by 81.6% for Up to 8 Months

Regeneron's COVID antibody cocktail purportedly cut infection risk by 81.6% (not quite as much as Pfizer's pill, but more than Merck's pill).

wearechange.org